May. 2 at 7:19 AM
$HYSR I've always trusted SH's decisions, and I still do. A company that relies on research results can never expect only success. Currently, however, it seems that success has returned, meaning, first and foremost, that the new panels are living up to the lab results. Without this fact—as others have already pointed out—no branch in Europe would have been opened. I'm curious to see what the company's future strategy will be. I imagine things will move quickly, starting with: 1. positive news about the pilot project; 2. an announcement about a second, larger pilot project; 3. the announcement of a collaboration (with cost coverage or cost sharing for the next pilot project) with ??? (Honda? Research funding?); and 4. the publication of a timeline for the next five years. And, if they're confident, a share buyback!
Tim, I'm in! 🍀 👉🏽👉🏽